The Nigeria Centre for Disease Control has announced the first confirmed case of the SARS-CoV-2 Delta variant, also known as lineage B.1.617.2.
According to NCDC’s report, the confirmed case is a traveller who came into Nigeria and underwent the routine travel test required of all international travelers and genomic sequencing at the NCDC National Reference Laboratory, Abuja.
TOS News reported in June that the World Health Organisation declared the Delta variant of the covid-19 as a variant of concern, given its increased transmissibility.
It noted that it is working with the Nigerian Institute of Medical Research, African Centre for Genomics of Infectious Diseases, and other laboratories within the national network, to carry out genomic sequencing as part of its response to COVID-19 in the country.
“This is to enable the detection of variants of concern and initiate response activities.
“All data on variants from Nigeria have been published on GISAID, a global mechanism for sharing sequencing data. Given the global risk of spread of the Delta variant, positive samples from international travelers to Nigeria are sequenced regularly.
“The Government of Nigeria through the Presidential Steering Committee has initiated several measures to reduce the risk of spread of COVID-19.
“This includes the introduction of travel restrictions from countries where there is a surge in cases associated with the widespread prevalence of variants of concern.
“The national travel protocol which include compulsory seven-day self-isolation and repeat test on the seventh day after arrival, are in place to reduce the risk of spread of the virus. It is very important that this is strictly adhered to, to prevent a surge in COVID-19 cases in Nigeria,” NCDC said.
Given the high transmissibility of the Delta variant and following its detection in Nigeria, NCDC urges all Nigerians to ensure strict adherence to public health and social measures in place.
NCDC added that the recommended control measures to limit the spread of the Delta variant continue to be testing, following the existing public health guidance and abiding by the current travel and public restrictions.